What Researchers Did
Researchers randomly assigned 34 patients with alopecia to either receive routine FUE hair transplantation or FUE combined with hyperbaric oxygen therapy (HBOT) daily for 7 days post-operation.
What They Found
Patients receiving HBOT experienced significantly less itching and folliculitis (11.8% vs 35.3% in controls) and a lower postoperative shedding rate (27.6% vs 69.1%). While early satisfaction was higher with HBOT (88.2% vs 52.9%), the 9-month hair follicle survival rate showed no significant difference between groups (96.9% vs 93.8%).
What This Means for Canadian Patients
For Canadian patients undergoing hair transplantation, adding hyperbaric oxygen therapy might reduce uncomfortable side effects like itching and folliculitis and decrease early hair shedding. However, it may not significantly improve the long-term survival rate of transplanted hair follicles, suggesting its main benefit is in early post-operative comfort.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.
Study Limitations
The study involved a relatively small sample size of 34 patients, which may limit the generalizability of the findings.